Calcimimetic agents and secondary hyperparathyroidism: treatment and prevention.
Goodman
William G
WG
D000814:Aniline Compounds / Q000627:therapeutic use; D002118:Calcium / Q000819:agonists*; D002986:Clinical Trials as Topic; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000517:prevention & control* / Q000628:therapy*; D006965:Hyperplasia; D010280:Parathyroid Glands / Q000473:pathology; D010627:Phenethylamines; D011437:Propylamines
D000814:Aniline Compounds; C107873:N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine; D010627:Phenethylamines; D011437:Propylamines; D002118:Calcium